NasdaqGS:LIVNMedical Equipment
LivaNova (LIVN), What Is Behind The Fresh Attention?
LivaNova (LIVN) drew fresh attention after raising its 2026 revenue growth guidance to 8% to 9% on a constant currency basis, alongside second quarter results that showed higher sales and net income.
See our latest analysis for LivaNova.
The raised guidance and strong second quarter figures have coincided with a 35.59% year to date share price return and a 53.05% total shareholder return over the past year, suggesting momentum in how the market is viewing LivaNova.
If LivaNova’s move has...